Navelbine and cough Patient Reports February 11, 2012

Navelbine Side Effects Report #4622844-3
Navelbine side effect was reported by a Health Professional from on Mar 25, 2005. Male patient, 57 years of age, was diagnosed with skin cancer , renal transplant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: aplasia, asthenia, chills, cough, leukopenia, neutropenia, productive cough, pyrexia. Navelbine dosage: unknown. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4750459-5
Navelbine side effect was reported by a Physician from FRANCE on Aug 17, 2005. Male patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: chest pain , cough, infusion related reaction, urticaria. Navelbine dosage: 25MGM2 PER DAY. During the same period patient was treated with ENDOXAN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4808555-X
Navelbine side effect was reported by a Physician from FRANCE on Aug 17, 2005. Male patient, child 2 years of age, was diagnosed with rhabdomyosarcoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: chest pain , cough, pruritus, rash , urticaria. Navelbine dosage: 9MGM2 CYCLIC. During the same period patient was treated with ENDOXAN, BACTRIM, MOVICOL. Patient recovered.

Navelbine Side Effects Report #5513094-7
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Oct 24, 2007. Male patient, 73 years of age, was diagnosed with pleural mesothelioma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cough, hypoxia, lung disorder, lung infiltration, pyrexia. Navelbine dosage: 0 MG QD IV. During the same period patient was treated with GEMZAR, NASEA, LOXONIN, CYTOTEC, FAMOTIDINE, HARNAL, CLEANAL. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #4740683-X
Navelbine side effect was reported by a Health Professional from JAPAN on Oct 22, 2004. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: bone marrow depression, cough, dysphonia, eczema , interstitial lung disease, phlebitis, pyrexia. Navelbine dosage: unknown. During the same period patient was treated with MAXIPIME, SELBEX, MOBIC, FERROUS SULPHATE, LOXOPROFEN, GEMZAR, POLARAMINE. Patient recovered.

Navelbine Side Effects Report #4694651-7
Navelbine side effect was reported by a Physician from on May 29, 2003. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain , choking , constipation , cough, cyanosis, disease progression, dyspnoea exacerbated. Navelbine dosage: 25MGM2 PER DAY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 05/12/2003.

Navelbine Side Effects Report #6133806-1
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 09, 2009. Male patient, 50 years of age, weighting 194.0 lb, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cough, dyspnoea. Navelbine dosage: 60 MG QD IV. Patient recovered.

Navelbine Side Effects Report #5989662-5
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 21, 2008. Male patient, weighting 194.0 lb, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cough, dyspnoea. Navelbine dosage: 60 MG QD IV. Patient recovered.

Navelbine Side Effects Report #4598253-2
Navelbine side effect was reported by a Physician from on Feb 25, 2005. Male patient, 76 years of age, was diagnosed with lymphoma  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, cough, delirium, febrile neutropenia, lobar pneumonia, malaise, oesophageal candidiasis, pharyngolaryngeal pain. Navelbine dosage: 37.5MG CYCLIC. During the same period patient was treated with GEMZAR, IFOSFAMIDE, PEGFILGRASTIM. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5500281-7
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on Oct 01, 2007. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cough, large intestine perforation, metastases to central nervous system, peritonitis. Navelbine dosage: 30 MG IV. During the same period patient was treated with AVASTIN. Patient died on 06/23/2006.

Navelbine Side Effects Report #4767222-1
Navelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2005. Female patient, 46 years of age, weighting 135.0 lb, was diagnosed with breast cancer , breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, cough, dyspnoea exertional, pulmonary toxicity. Navelbine dosage: 50 MG/M^2, ORAL. During the same period patient was treated with XELODA, ZOMETA, FLONASE, STEROID TAPER. Patient recovered.

Navelbine Side Effects Report #4768114-4
Navelbine side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2005. Female patient, 46 years of age, weighting 135.0 lb, was diagnosed with breast cancer , breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, cough, dyspnoea exertional, pulmonary toxicity. Navelbine dosage: 50 MG/M^2, ORAL. During the same period patient was treated with XELODA, ZOMETA, FLONASE, STEROID TAPER. Patient recovered.